Growth Metrics

Emergent BioSolutions (EBS) Other Working Capital Changes (2016 - 2026)

Emergent BioSolutions has reported Other Working Capital Changes over the past 17 years, most recently at $3.2 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes rose 133.68% year-over-year to $3.2 million; the TTM value through Mar 2026 reached $1.0 million, up 109.9%, while the annual FY2025 figure was -$11.7 million, 42.36% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was $3.2 million at Emergent BioSolutions, up from -$12.8 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $13.3 million in Q2 2023 and troughed at -$25.0 million in Q4 2022.
  • A 5-year average of -$2.6 million and a median of $500000.0 in 2023 define the central range for Other Working Capital Changes.
  • On a YoY basis, Other Working Capital Changes climbed as much as 4600.0% in 2025 and fell as far as 753.33% in 2025.
  • Year by year, Other Working Capital Changes stood at -$25.0 million in 2022, then soared by 50.4% to -$12.4 million in 2023, then skyrocketed by 87.9% to -$1.5 million in 2024, then crashed by 753.33% to -$12.8 million in 2025, then soared by 125.0% to $3.2 million in 2026.
  • Business Quant data shows Other Working Capital Changes for EBS at $3.2 million in Q1 2026, -$12.8 million in Q4 2025, and $1.2 million in Q3 2025.